ES2290337T3 - Metodos para aumentar los niveles de expresion del receptor tnf humano. - Google Patents

Metodos para aumentar los niveles de expresion del receptor tnf humano. Download PDF

Info

Publication number
ES2290337T3
ES2290337T3 ES02777356T ES02777356T ES2290337T3 ES 2290337 T3 ES2290337 T3 ES 2290337T3 ES 02777356 T ES02777356 T ES 02777356T ES 02777356 T ES02777356 T ES 02777356T ES 2290337 T3 ES2290337 T3 ES 2290337T3
Authority
ES
Spain
Prior art keywords
tnfred
proline
mutant
cells
expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES02777356T
Other languages
English (en)
Spanish (es)
Inventor
William Brondyk
Xuliang Jiang
Rene Lynn Schweickhardt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Serono SA
Serono Laboratories UK Ltd
Original Assignee
Laboratoires Serono SA
Serono Laboratories UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Serono SA, Serono Laboratories UK Ltd filed Critical Laboratoires Serono SA
Application granted granted Critical
Publication of ES2290337T3 publication Critical patent/ES2290337T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/14—Lymphokine; related peptides
    • Y10S930/144—Tumor necrosis factor

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)
ES02777356T 2001-11-30 2002-11-21 Metodos para aumentar los niveles de expresion del receptor tnf humano. Expired - Lifetime ES2290337T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34064801P 2001-11-30 2001-11-30
US340648P 2001-11-30

Publications (1)

Publication Number Publication Date
ES2290337T3 true ES2290337T3 (es) 2008-02-16

Family

ID=23334343

Family Applications (1)

Application Number Title Priority Date Filing Date
ES02777356T Expired - Lifetime ES2290337T3 (es) 2001-11-30 2002-11-21 Metodos para aumentar los niveles de expresion del receptor tnf humano.

Country Status (12)

Country Link
US (2) US7258997B2 (enExample)
EP (1) EP1448772B1 (enExample)
JP (1) JP2005535281A (enExample)
AT (1) ATE367438T1 (enExample)
AU (1) AU2002338947B2 (enExample)
CA (1) CA2466298A1 (enExample)
DE (1) DE60221273D1 (enExample)
DK (1) DK1448772T3 (enExample)
ES (1) ES2290337T3 (enExample)
IL (1) IL162133A0 (enExample)
PT (1) PT1448772E (enExample)
WO (1) WO2003046160A2 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7258997B2 (en) * 2001-11-30 2007-08-21 Applied Research Systems Ars Holding N.V. Methods of increasing protein expression levels
WO2005063813A2 (en) * 2003-12-23 2005-07-14 Applied Research Systems Ars Holding N.V. Process for the production of tumor necrosis factor-binding proteins
US8722348B2 (en) * 2008-05-28 2014-05-13 Wayne State University Method and composition for a protein transduction technology and its applications
PT2705143T (pt) 2011-05-02 2021-04-07 Univ Wayne State Tecnologia de células pluripotentes induzidas por proteínas e utilizações da mesma
KR102113829B1 (ko) 2013-10-25 2020-05-25 웨인 스테이트 유니버시티 단백질-유도 생체내 세포 재프로그래밍을 통한 세포 전환 방법, 시스템 및 조성물
CA3144637A1 (en) * 2019-06-21 2020-12-24 Kernal Biologics, Inc. Engineered oncoselective protein expression
JP2023522534A (ja) * 2020-02-03 2023-05-31 プレマス バイオテック プライベート リミテッド 発現が困難なタンパク質を発現させるための、組換え発現プラットフォーム、構築物、および方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE59010941D1 (de) 1989-04-21 2005-03-24 Amgen Inc TNF-Rezeptor, TNF bindende Proteine und dafür kodierende DNAs
EP0614353A1 (en) * 1991-11-25 1994-09-14 Richardson-Vicks, Inc. Compositions for regulating skin wrinkles and/or skin atrophy
IL107268A0 (en) 1993-10-12 1994-01-25 Yeda Res & Dev Molecules influencing the shedding of the tnf receptor, their preparation and their use
WO2002094864A2 (en) * 2001-05-25 2002-11-28 Genset S.A. Human cdnas and proteins and uses thereof
US7258997B2 (en) * 2001-11-30 2007-08-21 Applied Research Systems Ars Holding N.V. Methods of increasing protein expression levels

Also Published As

Publication number Publication date
CA2466298A1 (en) 2003-06-05
US7258997B2 (en) 2007-08-21
IL162133A0 (en) 2005-11-20
AU2002338947B2 (en) 2007-09-13
US20080014635A1 (en) 2008-01-17
DE60221273D1 (de) 2007-08-30
EP1448772B1 (en) 2007-07-18
PT1448772E (pt) 2007-10-02
AU2002338947A1 (en) 2003-06-10
US20050074840A1 (en) 2005-04-07
ATE367438T1 (de) 2007-08-15
EP1448772A2 (en) 2004-08-25
WO2003046160A2 (en) 2003-06-05
DK1448772T3 (da) 2007-11-19
WO2003046160A3 (en) 2003-07-31
JP2005535281A (ja) 2005-11-24

Similar Documents

Publication Publication Date Title
Cornish et al. Site-specific incorporation of biophysical probes into proteins.
US20210284698A1 (en) Stabilized soluble pre-fusion rsv f polypeptides
ES2280857T3 (es) Replegado de polipeptidos.
JP4972191B2 (ja) ペプチド、蛋白質及びペプチドミメティック合成のための方法及び組成物
US20080286834A1 (en) Leader Sequences For Directing Secretion of Polypeptides and Methods For Production Thereof
JP2003501035A (ja) 安定性に関して改変されたサイトカイン
JP2008500816A (ja) 改善された性質を有するｂｍｐ−７変異体
CN108884154A (zh) 具有独特剪接活性的断裂内含肽
EP0238101A1 (en) Microbial expression of interleukin II
EP4071178A1 (en) Method for producing peptide having physiological activity, and peptide comprising short linker
US20080014635A1 (en) Methods of increasing protein expression levels
ES2942024T3 (es) Métodos para caracterizar enlaces disulfuro
JP2004531225A5 (enExample)
KR20130020206A (ko) 수용성 ｂｍｐ-2를 생산하는 재조합 대장균 및 이를 이용한 수용성 ｂｍｐ-2의 제조방법
Tran et al. Evaluation of efficient non-reducing enzymatic and chemical ligation strategies for complex disulfide-rich peptides
ES2620410T3 (es) Selección de células que expresan polipéptidos heterómeros
ES2389835T3 (es) Glicoproteínas mutantes
IL192096A (en) Nucleic acid encoding fsh mutant, its preparation and pharmaceutical compositions containing it
CN103709253A (zh) 一种生物合成制备glp-1及其类似物的方法
CN112375741A (zh) 一种高表达sars-cov2-rbd的细胞株及其方法
RU2858871C1 (ru) Плазмиды для экспрессии рекомбинантного агониста рецептора глюкагоноподобного пептида-1 человека, слитого с кристаллизуемым фрагментом иммуноглобулина человека (дулаглутида), моноклональная линия клеток млекопитающих - продуцент дулаглутида, способ получения дулаглутида
RU2834784C1 (ru) Плазмида для экспрессии рекомбинантного хорионического гонадотропина человека (ХГЧ), плазмида для экспрессии рекомбинантных альфа- и бета-субъединиц ХГЧ, моноклональная линия клеток млекопитающих - продуцент ХГЧ, способ получения рекомбинантного ХГЧ
US9006393B1 (en) Molecular constructs and uses thereof in ribosomal translational events
Xu et al. De Novo Design and Directed Evolution Refinement of Mirror‐Image Protein Binders Targeting Interleukin‐4
ES2769500T3 (es) Proceso de preparación y purificación de la proteína oncostatina M humana recombinante